Outcome of assisted reproductive technology in women aged 40 years and older

被引:0
作者
Aflatoonian, Abbas [2 ]
Eftekhar, Maryam [2 ]
Mohammadian, Farnaz [1 ]
Yousefnejad, Fariba [2 ]
机构
[1] Zanjan Univ Med Sci, Dept Obstet & Gynecol, Zanjan, Iran
[2] Shahid Sadoughi Univ Med Sci, Res & Clin Ctr Infertil, Dept Obstet & Gynecol, Yazd, Iran
关键词
Advanced age; Assisted reproductive technology; Pregnancy rate; Live birth; IN-VITRO FERTILIZATION; INTRACYTOPLASMIC SPERM INJECTION; FOLLICLE-STIMULATING-HORMONE; AUTOLOGOUS OOCYTES; MATERNAL AGE; LIVE BIRTH; PREGNANCY; CYCLES; COST; INFERTILITY;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: Human fertility has been declined all over the world. Advanced women's age is one of the most important factors in determining the success of reproduction and ageing has negative impact on ART outcome and advanced female age decreases the chance of live birth rates achieved using ART, especially after 40 years of age. Objective: To evaluate ART outcomes regarding to pregnancy, abortion, cycle cancellation and live birth rates in women 40 years and older. Materials and Methods: A retrospective study was performed on three hundred-thirteen women undergoing ART cycles in the Madar Hospital in Yazd. Women with age >= 40 years who indicated for ART enrolled the study regardless of the infertility type or etiology. In this study, we used data from IVF or ICSI cycles using fresh embryo transfer. Follow up was performed in regard to pregnancy, abortion, cycle cancellation and live birth rates. Results: The mean age of women was 41.87 +/- 1.97 years. Chemical pregnancy rate was 8.6% (27/313) per cycle. Clinical pregnancy rate was 3.8% (12/313) per cycle. Spontaneous abortion was observed in 63% (17/27) of patients with positive pregnancy test. The overall cancellation rate was 23.3% per oocytes retrieval. The overall live birth rate per cycle for all women who initiated an ART cycle at age >= 40 years was 3.2% (10/313) that eight of those women were under 42 years old. Conclusion: Based on our results, we suggest that women with age 42 years and above should be advised to use other options, including oocyte donation or adoption.
引用
收藏
页码:281 / 284
页数:4
相关论文
共 26 条
[1]   Fertility and ageing [J].
Baird, DT ;
Collins, J ;
Egozcue, J ;
Evers, LH ;
Gianaroli, L ;
Leridon, H ;
Sunde, A ;
Templeton, A ;
Van Steirteghem, A ;
Cohen, J ;
Crosignani, PG ;
Devroey, P ;
Diedrich, K ;
Fauser, BCJM ;
Fraser, J ;
Glasier, A ;
Liebaers, I ;
Mautone, G ;
Penney, G ;
Tarlatzis, B .
HUMAN REPRODUCTION UPDATE, 2005, 11 (03) :261-276
[2]   In vitro fertilization in women over 40 years of age. A study on retrospective data for eight years [J].
Bongain, A ;
Castillon, JM ;
Isnard, V ;
Benoit, B ;
Donzeau, M ;
Gillet, JY .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1998, 76 (02) :225-231
[3]   Age is a better predictor of pregnancy potential than basal follicle-stimulating hormone levels in women undergoing in vitro fertilization [J].
Chuang, CC ;
Chen, CD ;
Chao, KH ;
Chen, SU ;
Ho, HN ;
Yang, YS .
FERTILITY AND STERILITY, 2003, 79 (01) :63-68
[4]   The influence of advanced age on the outcome of assisted reproduction [J].
Dew, JE ;
Don, RA ;
Hughes, GJ ;
Johnson, TC ;
Steigrad, SJ .
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 1998, 15 (04) :210-214
[5]   Controlled ovarian hyperstimulation interventions in infertile women aged 40 years or older undergoing in vitro fertilization [J].
Geng, Lihong ;
Li, Weihong ;
Li, Xiaohong ;
Qin, Lang ;
Xiao, Zhun ;
Li, Shangwei .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2009, 106 (03) :193-197
[6]  
George Korula, 2010, J Hum Reprod Sci, V3, P121, DOI 10.4103/0974-1208.74152
[7]   A cost-effectiveness analysis of in-vitro fertilization by maternal age and number of treatment attempts [J].
Griffiths, Alison ;
Dyer, Suzanne M. ;
Lord, Sarah J. ;
Pardy, Chris ;
Fraser, Ian S. ;
Eckermann, Simon .
HUMAN REPRODUCTION, 2010, 25 (04) :924-931
[8]   Intracytoplasmic sperm injection, results in women older than 39, according to age and the number of embryos replaced in selective or non-selective transfers [J].
Grimbizis, G ;
Vandervorst, M ;
Camus, M ;
Tournaye, H ;
Van Steirteghem, A ;
Devroey, P .
HUMAN REPRODUCTION, 1998, 13 (04) :884-889
[9]   PATIENT AGE AND SUCCESS IN A HUMAN IVF PROGRAM [J].
HARRISON, KL ;
BREEN, TM ;
HENNESSEY, JF ;
HYNES, MJ ;
KEEPING, JD ;
KILVERT, GT ;
DEAMBROSIS, PJW ;
MOLLOY, D .
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1989, 29 (03) :326-328
[10]   The combined effect of age and basal follicle-stimulating hormone on the cost of a live birth at assisted reproductive technology [J].
Henne, Melinda B. ;
Stegmann, Barbara J. ;
Neithardt, Adrienne B. ;
Catherino, William H. ;
Armstrong, Alicia Y. ;
Kao, Tzu-Cheg ;
Segars, James H. .
FERTILITY AND STERILITY, 2008, 89 (01) :104-110